Literature DB >> 9804091

Chronic bromvalerylurea intoxication: dystonic posture and cerebellar ataxia due to nonsteroidal anti-inflammatory drug abuse.

T Kawakami1, Y Takiyama, I Yanaka, T Taguchi, Y Tanaka, M Nishizawa, I Nakano.   

Abstract

Nalon-Ace and other nonsteroidal anti-inflammatory drugs (NSAID) containing bromvalerylurea (BVU) are sold as over-the-counter (OTC) drugs and are obtainable without prescription in Japan. A 32-year-old woman was diagnosed as having chronic BVU intoxication due to habitual use of Nalon-Ace. In addition to cerebellar ataxia and pyramidal signs well known in this condition, she showed an as yet non-described dystonic posture of the neck. Laboratory tests revealed an elevated concentration of serum organic bromide, iron deficiency anemia, and hyperchloremia. Brain magnetic resonance imaging (MRI) revealed definite cerebellar atrophy. We should consider the possibility of chronic BVU intoxication in peculiar neurological cases like ours.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804091     DOI: 10.2169/internalmedicine.37.788

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Reversible dysphagia and dementia in a patient with bromide intoxication.

Authors:  C Y Yu; P K Yip; Y C Chang; M J Chiu
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

2.  A case of acute bromvalerylurea intoxication that was successfully treated with direct hemoperfusion.

Authors:  Ken Ishikura; Kan Katayama; Akiko Hara; Hirokazu Kotani; Kei Suzuki; Tadashi Kaneko; Kaoru Dohi; Hiroshi Imai
Journal:  CEN Case Rep       Date:  2021-11-24

3.  Bromisoval-induced bromism with status epilepticus mimicking Wernicke's encephalopathy: report of two cases.

Authors:  Masahiro Biyajima; Shunichi Satoh; Takahiro Morikawa; Yuki Morita; Rie Watanabe; Daisuke Matsui; Masataka Konno; Nobutoshi Morimoto; Yuichi Yatsu; Akihito Hirasaki; Hiroyuki Yahikozawa
Journal:  BMC Neurol       Date:  2022-05-16       Impact factor: 2.903

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.